| Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity F Chibon, P Lagarde, S Salas, G Pérot, V Brouste, F Tirode, C Lucchesi, ... Nature medicine 16 (7), 781-787, 2010 | 474 | 2010 |
| Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters F Bertucci, S Salas, S Eysteries, V Nasser, P Finetti, C Ginestier, ... Oncogene 23 (7), 1377-1391, 2004 | 443 | 2004 |
| Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation S Salas, A Dufresne, B Bui, JY Blay, P Terrier, D Ranchere-Vince, ... Journal of Clinical Oncology 29 (26), 3553-3558, 2011 | 398 | 2011 |
| A prognostic nomogram for prediction of recurrence in desmoid fibromatosis AM Crago, B Denton, S Salas, A Dufresne, JJ Mezhir, M Hameed, ... Annals of surgery 258 (2), 347-353, 2013 | 292 | 2013 |
| Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial O Mir, T Brodowicz, A Italiano, J Wallet, JY Blay, F Bertucci, C Chevreau, ... The lancet oncology 17 (12), 1732-1742, 2016 | 262 | 2016 |
| Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG) D Garbay, A Le Cesne, N Penel, C Chevreau, P Marec-Berard, JY Blay, ... Annals of Oncology 23 (1), 182-186, 2012 | 180 | 2012 |
| Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma Group N Penel, A Le Cesne, S Bonvalot, A Giraud, E Bompas, M Rios, S Salas, ... European journal of cancer 83, 125-131, 2017 | 166 | 2017 |
| High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management J Dômont, S Salas, L Lacroix, V Brouste, P Saulnier, P Terrier, ... British journal of cancer 102 (6), 1032-1036, 2010 | 160 | 2010 |
| Adult desmoid tumors: biology, management and ongoing trials N Penel, F Chibon, S Salas Current Opinion in Oncology 29 (4), 268-274, 2017 | 159 | 2017 |
| Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database S Salas, N Resseguier, JY Blay, A Le Cesne, A Italiano, C Chevreau, ... Annals of oncology 28 (8), 1779-1787, 2017 | 143 | 2017 |
| Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: prospective randomized trial S Salas, K Baumstarck-Barrau, M Alfonsi, L Digue, D Bagarry, N Feham, ... Radiotherapy and Oncology 93 (3), 503-509, 2009 | 137 | 2009 |
| Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors S Salas, F Chibon, T Noguchi, P Terrier, D RanchereVince, P Lagarde, ... Genes, Chromosomes and Cancer 49 (6), 560-568, 2010 | 126 | 2010 |
| Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis ML Janssen, DLM Van Broekhoven, JMM Cates, WM Bramer, JJ Nuyttens, ... Journal of British Surgery 104 (4), 347-357, 2017 | 124 | 2017 |
| The CareGiver Oncology Quality of Life questionnaire (CarGOQoL): development and validation of an instrument to measure the quality of life of the caregivers of patients with … P Minaya, K Baumstarck, J Berbis, A Goncalves, F Barlesi, G Michel, ... European Journal of Cancer 48 (6), 904-911, 2012 | 115 | 2012 |
| Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO) E Bompas, A Le Cesne, E Tresch-Bruneel, L Lebellec, V Laurence, ... Annals of Oncology 26 (10), 2168-2173, 2015 | 108 | 2015 |
| Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies J Strauss, ME Gatti-Mays, BC Cho, A Hill, S Salas, E McClay, JM Redman, ... Journal for immunotherapy of cancer 8 (2), 2020 | 106 | 2020 |
| Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma S Salas, JL Deville, R Giorgi, T Pignon, D Bagarry, K Barrau, M Zanaret, ... Radiotherapy and Oncology 87 (2), 195-200, 2008 | 104 | 2008 |
| A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation F Le Loarer, AHG Cleven, C Bouvier, MP Castex, C Romagosa, A Moreau, ... Modern Pathology 33 (3), 404-419, 2020 | 101 | 2020 |
| Impact on healthrelated quality of life of parenteral nutrition for patients with advanced cancer cachexia: Results from a randomized controlled trial C Bouleuc, A Anota, C Cornet, G Grodard, A ThieryVuillemin, ... The Oncologist 25 (5), e843-e851, 2020 | 90 | 2020 |
| Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care S Salas, M Frasca, B Planchet-Barraud, B Burucoa, M Pascal, JM Lapiana, ... Journal of palliative medicine 15 (3), 287-293, 2012 | 82 | 2012 |
